At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...
MedPage Today on MSN
CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma
Study suggests CD4+ T cells mediate these immune-related toxicities ...
Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Impact of 24 months of androgen deprivation therapy (ADT) on physical function in men with nonmetastatic prostate cancer. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients ...
Identification of functional DNA methylation aberrations associated with outcome in melanoma patients with brain metastasis. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
(A) Principal component analysis (PCA) of lymphocyte subsets and factors such as age in Control, LC, and LC-PTB groups, and the joint analysis of LC & LC-PTB. PC1 and PC2 represent the first and ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to restore immune competence, today announced updated Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results